Russell Investments Group, Ltd. Fate Therapeutics Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 62,870 shares of FATE stock, worth $104,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,870

Previous 101,933 38.32%

Holding current value

$104,364

Previous $334,000 34.13%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.12 - $5.57 $121,876 - $217,580	-39,063 Reduced 38.32%	62,870 $220,000
Q2 2024 Aug 08, 2024	SELL	$3.26 - $7.08 $27,106 - $58,870	-8,315 Reduced 7.54%	101,933 $334,000
Q1 2024 May 08, 2024	SELL	$3.54 - $8.35 $437,190 - $1.03 Million	-123,500 Reduced 52.83%	110,248 $809,000
Q4 2023 Feb 05, 2024	BUY	$1.65 - $3.94 $97,790 - $233,511	59,267 Added 33.97%	233,748 $874,000
Q3 2023 Nov 13, 2023	SELL	$2.02 - $5.04 $26,249 - $65,494	-12,995 Reduced 6.93%	174,481 $369,000
Q2 2023 Aug 10, 2023	BUY	$4.76 - $6.59 $73,237 - $101,393	15,386 Added 8.94%	187,476 $892,000
Q1 2023 May 09, 2023	BUY	$4.24 - $11.12 $727,418 - $1.91 Million	171,561 Added 32431.19%	172,090 $980,000
Q3 2021 Nov 08, 2021	SELL	$59.27 - $95.73 $260,491 - $420,733	-4,395 Reduced 89.26%	529 $31,000
Q2 2021 Aug 04, 2021	SELL	$67.25 - $92.52 $2.27 Million - $3.13 Million	-33,812 Reduced 87.29%	4,924 $427,000
Q1 2021 May 10, 2021	SELL	$72.16 - $117.4 $1.51 Million - $2.46 Million	-20,912 Reduced 35.06%	38,736 $3.19 Million
Q4 2020 Feb 08, 2021	SELL	$38.09 - $100.95 $327,688 - $868,472	-8,603 Reduced 12.6%	59,648 $5.43 Million
Q2 2020 Aug 05, 2020	SELL	$20.21 - $35.23 $623,013 - $1.09 Million	-30,827 Reduced 31.11%	68,251 $2.34 Million
Q1 2020 May 06, 2020	SELL	$17.28 - $31.88 $1.01 Million - $1.86 Million	-58,280 Reduced 37.04%	99,078 $2.2 Million
Q4 2019 Jan 29, 2020	BUY	$13.39 - $20.73 $892,858 - $1.38 Million	66,681 Added 73.54%	157,358 $3.08 Million
Q3 2019 Nov 01, 2019	BUY	$15.47 - $22.5 $1.4 Million - $2.04 Million	90,677 New	90,677 $1.41 Million
Q4 2017 Feb 06, 2018	SELL	$3.94 - $6.64 $233,121 - $392,875	-59,168 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$2.6 - $4.31 $153,836 - $255,014	59,168	59,168 $234,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Fate Therapeutics Inc Transaction History